{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:14:02Z","timestamp":1779344042675,"version":"3.51.4"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive dysfunction is prevalent in patients with depressive symptoms and contributes to impaired quality of life (QOL) and functional outcomes. However, the prognostic significance of specific cognitive domains for long-term outcomes remains unclear in patients with persistent depressive symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective observational study, 119 patients completed the detailed examination program in routine clinical care. Of these, 84 patients with persistent depressive symptoms provided consent for study participation and met the eligibility criteria for inclusion in the present study, including completion of the baseline assessment with the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV). The diagnostically heterogeneous cohort included patients with major depressive disorder\/dysthymia as well as bipolar and related disorders. The World Health Organization Quality of Life Instrument, Short Version (WHO-QOL-26) and the World Health Organization Disability Assessment Schedule 2.0 were assessed at baseline, three, and six months; 60 participants provided 3-month follow-up data and 50 provided 6-month follow-up data. Primary hierarchical regression analyses were exploratory and conducted using complete-case data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At baseline, participants exhibited relatively higher verbal ability and lower processing speed compared to normative data. While no significant group-level improvement in QOL was observed over six months and functioning did not improve overall, the WHODAS 2.0 standardized total score was temporarily higher at 3 months than at baseline. In exploratory analyses of complete cases, higher baseline working memory was significantly associated with greater improvement in the psychological domain of the WHO-QOL-26 at six months (\u03b2 = 0.40; \u0394R\u00b2 = 0.14; p &amp;lt; 0.01). No other cognitive domains showed such associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Working memory was associated with subsequent improvement in psychological well-being and may represent a candidate prognostic marker in patients with persistent depressive symptoms. Given the exploratory nature and modest sample size, these findings require replication in larger, diverse populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1838340","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:46:00Z","timestamp":1779342360000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline working memory was associated with improvement in psychological quality of life in patients with persistent depressive symptoms: a prospective observational study"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuki","family":"Oe","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry, Kyorin University School of Medicine","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Kyorin University School of Medicine","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonari","family":"Hayasaka","sequence":"additional","affiliation":[{"name":"Department of Occupational Therapy, Kyorin University School of Health Sciences","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Department of Occupational Therapy, Kyorin University School of Health Sciences","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Murao","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Kyorin University School of Medicine","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Kyorin University School of Medicine","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Takaesu","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus","place":["Ginowan, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Kyorin University School of Medicine","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Kyorin University School of Medicine","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Kyorin University School of Medicine","place":["Mitaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21169","article-title":"Cumulative remission rate after sequential treatments in depression: reappraisal of the STAR*D trial data","volume":"23","author":"Sakurai","year":"2024","journal-title":"World Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.02.023","article-title":"The identification, assessment and management of difficult-to-treat depression: An international consensus statement","volume":"267","author":"McAllister-Williams","year":"2020","journal-title":"J Affect Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment\u2010resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0004867418808585","article-title":"Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive","volume":"53","author":"Rush","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12991-023-00478-7","article-title":"Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel","volume":"22","author":"Maina","year":"2023","journal-title":"Ann Gen Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1371242","article-title":"Sociodemographic and clinical characteristics of suspected difficult-to-treat depression","volume":"15","author":"Murao","year":"2024","journal-title":"Front Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13385","article-title":"Functional and cognitive impairment in the first episode of depression: A systematic review","volume":"145","author":"Varghese","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30291-3","article-title":"Cognitive function following a major depressive episode: a systematic review and meta-analysis","volume":"6","author":"Semkovska","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2020.65","article-title":"Is cognitive dysfunction involved in difficult-to-treat depression? Characterizing resistance from a cognitive perspective","volume":"63","author":"L\u00f3pez-Sol\u00e0","year":"2020","journal-title":"Eur Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S226405","article-title":"Comparative study of cognitive function between treatment-resistant depressive patients and first-episode depressive patients","volume":"15","author":"Rao","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13r08939","article-title":"The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review","volume":"75","author":"Evans","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.psychres.2005.11.011","article-title":"Neurocognitive deficits and disability in major depressive disorder","volume":"145","author":"Jaeger","year":"2006","journal-title":"Psychiatry Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2018.08.033","article-title":"The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review","volume":"269","author":"Cambridge","year":"2018","journal-title":"Psychiatry Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00382","article-title":"A Systematic Review of cognitive predictors of treatment outcome in major depression","volume":"9","author":"Groves","year":"2018","journal-title":"Front Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2008.12.001","article-title":"The role of cognitive impairment in general functioning in major depression","volume":"176","author":"Baune","year":"2010","journal-title":"Psychiatry Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13071120","article-title":"Evolution of cognitive impairments in treatment-resistant depression: results from the longitudinal french centers of expertise for treatment-resistant depression (FACE-DR) cohort","volume":"13","author":"Vancappel","year":"2023","journal-title":"Brain Sci"},{"key":"B19","volume-title":"Treatment guideline for major depressive disorder","year":"2017"},{"key":"B20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group","volume":"13","author":"Skevington","year":"2004","journal-title":"Qual Life Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/2055102915598089","article-title":"The psychometric properties of the WHOQOL-BREF in Japanese couples","volume":"2","author":"Yoshitake","year":"2015","journal-title":"Health Psychol Open"},{"key":"B22","volume-title":"Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0)","author":"Tazaki","year":"2015"},{"key":"B23","volume-title":"Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0)","author":"\u00dcst\u00fcn","year":"2010"},{"key":"B24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1017\/S0033291709006011","article-title":"Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report","volume":"40","author":"Nierenberg","year":"2010","journal-title":"Psychol Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1037\/0033-295X.103.3.403","article-title":"The processing-speed theory of adult age differences in cognition","volume":"103","author":"Salthouse","year":"1996","journal-title":"Psychol Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00140.x","article-title":"Symptomatic recovery and social functioning in major depression","volume":"103","author":"Furukawa","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719001612","article-title":"Long-term disability in major depressive disorder: a 6-year follow-up study","volume":"50","author":"Iancu","year":"2020","journal-title":"Psychol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116655","article-title":"Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group","volume":"352","author":"d\u2019Andrea","year":"2025","journal-title":"Psychiatry Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1736114","article-title":"Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality","volume":"16","author":"Olivola","year":"2026","journal-title":"Front Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15041629","article-title":"Integrating psychiatric, psychotherapeutic, and nursing care in intranasal esketamine for treatment-resistant depression","volume":"15","author":"Martiadis","year":"2026","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100272","article-title":"Cognitive impairments in treatment-resistant depression: results from the French cohort of outpatients (FACE-DR)","volume":"6","author":"Vancappel","year":"2021","journal-title":"J Affect Disord Rep"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1838340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:46:04Z","timestamp":1779342364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1838340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":31,"alternative-id":["10.3389\/fpsyt.2026.1838340"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1838340","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1838340"}}